Company Profiles

driven by the PitchBook Platform

nLife Therapeutics

Description

Developer of nucleic acid pharmaceutical products. The company discovers and delivers oligonucleotides as therapeutic agents for central nervous system disorders.

2009

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$350k

Latest Deal Amount

$19.3M

Total Amount Raised

Description

Developer of nucleic acid pharmaceutical products. The company discovers and delivers oligonucleotides as therapeutic agents for central nervous system disorders.

Website:

www.n-life.es

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Delivery
Drug Discovery

Primary Office

Parque Tecnológico de Ciencias de la Salud, Eficio Bic-Granada, Nave 5 Avda. de la Innovacion, 1 18100 ArmillaSpain +34 95 750 599
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore nLife Therapeutics's full profile, request a free trial.

nLife Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

nLife Therapeutics Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Caixa Capital RiscCorporate Venture CapitalMinority000 0000000 0000
Cross Road BiotechVenture CapitalMinority000 0000000 0000
HealthEquityCorporationMinority000 0000000 0000
Healthequity (Spain)Venture CapitalMinority000 0000000 0000
Inversión y Gestión de Capital Riesgo de AndalucíaVenture CapitalMinority000 0000000 0000
Caixa Capital Risc Corporate Venture Capital
Cross Road Biotech Venture Capital
HealthEquity Corporation
Healthequity (Spain) Venture Capital
Inversión y Gestión de Capital Riesgo de Andalucía Venture Capital

nLife Therapeutics Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Andres MontefeltroChief Executive Officer
Raquel Revilla Sanchez Ph.DPrincipal, Neurodegenerative Diseases
Theresa BranchekChief Scientific Officer
Gabriel Alvarado Ph.DDirector, Chemistry
Marina Santos Ph.DHead, Laboratory
Andres Montefeltro Chief Executive Officer
Raquel Revilla Sanchez Ph.D Principal, Neurodegenerative Diseases
Theresa Branchek Chief Scientific Officer
Gabriel Alvarado Ph.D Director, Chemistry
Marina Santos Ph.D Head, Laboratory

nLife Therapeutics Board Members (3)

NameRepresentingRoleSinceContact
Info
Inmaculada Valle Ph.DCaixa Capital RiscBoard Member000 0000
José Antonio MesaCaixa Capital RiscInvestment Director000 0000
Ronald Lorijn Ph.DSelfNon-Executive Board Director000 0000
Inmaculada Valle Ph.D Board Member Caixa Capital Risc
José Antonio Mesa Investment Director Caixa Capital Risc
Ronald Lorijn Ph.D Non-Executive Board Director Self
Request full access to PitchBook